Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/11/2019
SIETES contiene 92834 citas

 
 
 1 a 20 de 167 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Franco OH, Chowdhury R, Troup J, Voortman T, Kunutsor S, Kavousi M, Oliver-Williams C, Muka T. Use of plant-based therapies and menopausal symptoms. A systematic review and meta-analysis. JAMA 2016;315:2554-63. [Ref.ID 100434]
2. Cita con resumen
Qaseem A, Barry MJ, Kansagara D, for the Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;164:350-9. [Ref.ID 99996]
3. Cita con resumen
Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ 2014;348:g1626. [Ref.ID 97343]
5. Cita con resumen
Briggs JP, Killen J. Perspectives on complementary and alternative medicine research. JAMA 2013;310:691-2. [Ref.ID 95950]
6.Enlace a cita original
Posadzki P, Watson L, Ernst E. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. Eur J Clin Pharmacol 2013;69:295-307. [Ref.ID 95150]
7.Enlace a cita original Cita con resumen
Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol 2013;75:603-18. [Ref.ID 95037]
9.
Skalli S, Bencheikh RS. Safety monitoring of herb-drug interactions: a component of pharmacovigilance. Drug Saf 2012;35:785-91. [Ref.ID 93810]
10.Enlace a cita original
Tsai HH, Lin HW, Pickard SA, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice 2012;66:1056-78. [Ref.ID 93669]
11.Enlace a cita original
Bosch M, Bonafont X. Efecte de l'ús de plantes medicinals en el període perioperatori. Butlletí d'Informació Terapèutica 2009;21:19-24. [Ref.ID 86922]
14.Tiene citas relacionadas
Stoney CM, Coates P, Briggs JP. Integrity of active components of botanical products used in complementary and alternative medicine. JAMA 2008;300:1995. [Ref.ID 84422]
15. Cita con resumen
Weber W, Stoep AV, McCarty RL, Weiss NS, Biederman J, McClellan J. Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents. A randomized controlled trial. JAMA 2008;299:2633-41. [Ref.ID 83198]
16. Cita con resumen
Baxter K, Sharp JM. Adverse drug interactions. Adv Drug React Bull 2008;248:951-4. [Ref.ID 82877]
17. Cita con resumen
Nelson HD. Menopause. Lancet 2008;371:760-70. [Ref.ID 82270]
18.
Andrén L, Andreasson A, Eggertsen R. Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients whith hypercholesterolemia. Eur J Clin Pharmacol 2007;63:913-6. [Ref.ID 81285]
19. Cita con resumen
Thanacoody RHK. Serotonin syndrome. Adv Drug React Bull 2007;243:931-4. [Ref.ID 81222]
20.
Giner V, Papalardo E, Lafuente P, Esteban MJ. Fiebre prolongada por la ingesta de Hypericum perforatum (hierba de San Juan). Med Clin (Barc) 2007;129:356-7. [Ref.ID 81126]
Seleccionar todas
 
 1 a 20 de 167 siguiente >>